We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why Oscar Health, Inc. (OSCR) Fell More Than Broader Market
Read MoreHide Full Article
In the latest trading session, Oscar Health, Inc. (OSCR - Free Report) closed at $32.62, marking a -3.53% move from the previous day. This change lagged the S&P 500's 0.45% loss on the day. At the same time, the Dow lost 0.63%, and the tech-heavy Nasdaq lost 0.78%.
The company's stock has climbed by 7.16% in the past month, exceeding the Finance sector's loss of 2.1% and the S&P 500's loss of 1.99%.
Analysts and investors alike will be keeping a close eye on the performance of Oscar Health, Inc. in its upcoming earnings disclosure. The company's earnings per share (EPS) are projected to be -$0.27, reflecting a 49.06% increase from the same quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $4.72 billion, indicating a 58.14% growth compared to the corresponding quarter of the prior year.
For the full year, the Zacks Consensus Estimates project earnings of $1.54 per share and a revenue of $18.81 billion, demonstrating changes of +191.12% and +60.77%, respectively, from the preceding year.
Investors should also take note of any recent adjustments to analyst estimates for Oscar Health, Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Currently, Oscar Health, Inc. is carrying a Zacks Rank of #1 (Strong Buy).
Looking at its valuation, Oscar Health, Inc. is holding a Forward P/E ratio of 21.91. This signifies a premium in comparison to the average Forward P/E of 10.37 for its industry.
Meanwhile, OSCR's PEG ratio is currently 0.5. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. As of the close of trade yesterday, the Insurance - Multi line industry held an average PEG ratio of 0.87.
The Insurance - Multi line industry is part of the Finance sector. Currently, this industry holds a Zacks Industry Rank of 75, positioning it in the top 31% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Here's Why Oscar Health, Inc. (OSCR) Fell More Than Broader Market
In the latest trading session, Oscar Health, Inc. (OSCR - Free Report) closed at $32.62, marking a -3.53% move from the previous day. This change lagged the S&P 500's 0.45% loss on the day. At the same time, the Dow lost 0.63%, and the tech-heavy Nasdaq lost 0.78%.
The company's stock has climbed by 7.16% in the past month, exceeding the Finance sector's loss of 2.1% and the S&P 500's loss of 1.99%.
Analysts and investors alike will be keeping a close eye on the performance of Oscar Health, Inc. in its upcoming earnings disclosure. The company's earnings per share (EPS) are projected to be -$0.27, reflecting a 49.06% increase from the same quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $4.72 billion, indicating a 58.14% growth compared to the corresponding quarter of the prior year.
For the full year, the Zacks Consensus Estimates project earnings of $1.54 per share and a revenue of $18.81 billion, demonstrating changes of +191.12% and +60.77%, respectively, from the preceding year.
Investors should also take note of any recent adjustments to analyst estimates for Oscar Health, Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Currently, Oscar Health, Inc. is carrying a Zacks Rank of #1 (Strong Buy).
Looking at its valuation, Oscar Health, Inc. is holding a Forward P/E ratio of 21.91. This signifies a premium in comparison to the average Forward P/E of 10.37 for its industry.
Meanwhile, OSCR's PEG ratio is currently 0.5. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. As of the close of trade yesterday, the Insurance - Multi line industry held an average PEG ratio of 0.87.
The Insurance - Multi line industry is part of the Finance sector. Currently, this industry holds a Zacks Industry Rank of 75, positioning it in the top 31% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.